Literature DB >> 3019537

Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse.

A A Kyriazis, A P Kyriazis, C N Sternberg, N H Sloane, J D Loveless.   

Abstract

Human pancreatic ductal adenocarcinoma Capan-2, derived from a 56-yr-old male Caucasian, has been studied in both tissue culture and the nude mouse. In tissue culture, tumor cells showed epithelial-like features, whereas in the nude mouse, the tumor grew as a well-differentiated adenocarcinoma, resembling histopathologically the original neoplasm. Ultrastructurally, the neoplastic cells showed characteristics of ductal epithelium. The allozyme phenotypic profile of Tumor Capan-2 was determined in eight genetically determined loci, and chromosome studies showed a hypotetraploid pattern with a number of morphological and numerical changes. Carcinoembryonic antigen was produced in trace amounts, and lactate dehydrogenase was represented only by Isoenzyme 5, regardless of environmental conditions. The characteristics of Capan-2 tumor make it a valuable addition to the small number of available pancreatic tumor lines in studies aiming at clarifying certain aspects of the biology of this type of malignancy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019537

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

Authors:  W R Gower; R M Risch; C V Godellas; P J Fabri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

2.  Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis.

Authors:  Oliver G McDonald; Xin Li; Tyler Saunders; Rakel Tryggvadottir; Samantha J Mentch; Marc O Warmoes; Anna E Word; Alessandro Carrer; Tal H Salz; Sonoko Natsume; Kimberly M Stauffer; Alvin Makohon-Moore; Yi Zhong; Hao Wu; Kathryn E Wellen; Jason W Locasale; Christine A Iacobuzio-Donahue; Andrew P Feinberg
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

3.  p53 mutations change phosphatidylinositol acyl chain composition.

Authors:  Adam Naguib; Gyula Bencze; Dannielle D Engle; Iok I C Chio; Tali Herzka; Kaitlin Watrud; Szilvia Bencze; David A Tuveson; Darryl J Pappin; Lloyd C Trotman
Journal:  Cell Rep       Date:  2014-12-24       Impact factor: 9.423

Review 4.  Phenotype and genotype of pancreatic cancer cell lines.

Authors:  Emily L Deer; Jessica González-Hernández; Jill D Coursen; Jill E Shea; Josephat Ngatia; Courtney L Scaife; Matthew A Firpo; Sean J Mulvihill
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

5.  Establishment and characterization of a new transplantable pancreatic cancer xenograft (PZX-5) in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; F Timár; I Babó
Journal:  Int J Pancreatol       Date:  1998-02

6.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 8.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

9.  Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells.

Authors:  S De Breuck; J Lardon; I Rooman; L Bouwens
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

10.  Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells.

Authors:  Haley L Peters; Amit Tuli; Xiaojian Wang; Cuiling Liu; Zenggang Pan; Michel M Ouellette; Michael A Hollingsworth; Richard G Macdonald; Joyce C Solheim
Journal:  Int J Oncol       Date:  2012-07-13       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.